| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Departments of Anatomy [Y. W., A. A. D., P. Y., G. R. C.], Urology [S. W. H., R. D., G. R. C.], University of California, San Francisco, California 94143-0452; Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [T. J., J. S.]; University of California Davis Center for Comparative Medicine, University of California, Davis, California 95616 [R. D. C.]; and Department of Surgery, Division of Urology, University of Michigan Comprehensive Cancer Center, University of Michigan Ann Arbor, Michigan 48109 [M. L. D.]
The retinoblastoma (Rb) gene product is a prototypic tumor suppressor.
Mice lacking the Rb gene are not viable and die
in utero at 
13 days of gestation. In this study, we
have rescued Rb-/- prostates by grafting pelvic organ
rudiments from Rb-/- mouse embryos under the renal
capsule of adult male nude mouse hosts. Grafts of embryonic pelvic
organs developed into functional prostatic tissue. Some of the
prostatic tissue generated was further used to construct chimeric
prostatic tissue recombinants by combining wild-type rat urogenital
mesenchyme (rUGM) with Rb-/- and Rb+/+
prostatic epithelium (PRE). The tissue recombinants were grown as
subcapsular renal grafts and treated from the time of grafting with
Silastic capsules containing 25 mg of testosterone plus 2.5 mg of
estradiol. During 5–8 weeks of hormone treatment,
rUGM+Rb+/+PRE tissue recombinants developed prostatic
hyperplasia, whereas PRE in rUGM+Rb-/-PRE tissue
recombinants developed hyperplasia, atypical hyperplasia, and
carcinoma. During carcinogenesis in rUGM+Rb-/-PRE tissue
recombinants, prostatic epithelial cells of the basal lineage
disappeared, whereas the luminal cells underwent carcinogenesis.
Epithelial E-cadherin almost totally disappeared. In all cases,
epithelial PCNA labeling was elevated in tissue recombinants containing
Rb-/- versus Rb+/+ epithelium.
These epithelial changes were associated with almost total loss of
smooth muscle cells in the stroma. In contrast, in untreated hosts
rUGM+Rb+/+PRE tissue recombinants developed normally, and
rUGM+Rb-/-PRE tissue recombinants developed mild
epithelial hyperplasia. The results of this study demonstrate that
Rb-/- prostatic tissue can be rescued from embryonic
lethal mice and used to test its susceptibility to hormonal
carcinogenesis. Deletion of the Rb gene predisposes
prostatic epithelium to hyperplasia and increases proliferative
activity. Susceptibility to hormonal carcinogenesis in response to
exogenous testosterone + estradiol is manifested in the
progression from atypical hyperplasia to carcinoma. Thus, these
findings demonstrate that the absence of the Rb tumor
suppressor gene may predispose prostatic epithelial cells to
carcinogenesis. Rescue of organs from Rb-/- embryos not
only provides an opportunity to analyze the Rb gene
pathway in the development and progression of prostate cancer but also
provides an opportunity for specifically evaluating the role of the Rb
pathway in development and carcinogenesis in other organs, such as the
mammary gland and colon. Because rUGM greatly stimulates prostatic
epithelial proliferation, the tissue recombinant model is a
particularly useful tool for assessing the functional role of other
genes in prostatic carcinogenesis through use of the appropriate
transgenic or gene knockout mice.
This article has been cited by other articles:
|
|
 |
|
  S. Smith, D. Sepkovic, H. L. Bradlow, and K. J. Auborn 3,3'-Diindolylmethane and Genistein Decrease the Adverse Effects of Estrogen in LNCaP and PC-3 Prostate Cancer Cells J. Nutr., December 1, 2008; 138(12): 2379 - 2385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Yao, A. Parwani, C. Maier, W. D. Heston, and D. J. Bacich Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis Cancer Res., November 1, 2008; 68(21): 9070 - 9077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Ricke, S. J. McPherson, J. J. Bianco, G. R. Cunha, Y. Wang, and G. P. Risbridger Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J, May 1, 2008; 22(5): 1512 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chiaverotti, S. S. Couto, A. Donjacour, J.-H. Mao, H. Nagase, R. D. Cardiff, G. R. Cunha, and A. Balmain Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer Am. J. Pathol., January 1, 2008; 172(1): 236 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Hydock, C.-Y. Lien, C. M. Schneider, and R. Hayward Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3254 - H3264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Kaseb, K. Chinnakannu, D. Chen, A. Sivanandam, S. Tejwani, M. Menon, Q. P. Dou, and G. P.-V. Reddy Androgen Receptor and E2F-1 Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer Cancer Res., August 15, 2007; 67(16): 7782 - 7788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sharma, C. E.S. Comstock, E. S. Knudsen, K. H. Cao, J. K. Hess-Wilson, L. M. Morey, J. Barrera, and K. E. Knudsen Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6192 - 6203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhou, A. Flesken-Nikitin, D. C. Corney, W. Wang, D. W. Goodrich, P. Roy-Burman, and A. Yu. Nikitin Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer Cancer Res., August 15, 2006; 66(16): 7889 - 7898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lamb and L. Zhang Challenges in Prostate Cancer Research: Animal Models for Nutritional Studies of Chemoprevention and Disease Progression J. Nutr., December 1, 2005; 135(12): 3009S - 3015S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hill, Y. Song, R. D. Cardiff, and T. Van Dyke Heterogeneous Tumor Evolution Initiated by Loss of pRb Function in a Preclinical Prostate Cancer Model Cancer Res., November 15, 2005; 65(22): 10243 - 10254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Cunha, N. J. Place, L. Baskin, A. Conley, M. Weldele, T. J. Cunha, Y.Z. Wang, M. Cao, and S. E. Glickman The Ontogeny of the Urogenital System of the Spotted Hyena (Crocuta crocuta Erxleben) Biol Reprod, September 1, 2005; 73(3): 554 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gao, K. Ishii, J. Mirosevich, S. Kuwajima, S. R. Oppenheimer, R. L. Roberts, M. Jiang, X. Yu, S. B. Shappell, R. M. Caprioli, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation Development, August 1, 2005; 132(15): 3431 - 3443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. McCabe, J. N. Davis, and M. L. Day Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway Cancer Res., May 1, 2005; 65(9): 3624 - 3632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Davis, M. T. McCabe, S. W. Hayward, J. M. Park, and M. L. Day Disruption of Rb/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells Cancer Res., May 1, 2005; 65(9): 3633 - 3642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kurita, R. T. Medina, A. A. Mills, and G. R. Cunha Role of p63 and basal cells in the prostate Development, October 15, 2004; 131(20): 4955 - 4964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Maddison, B. W. Sutherland, R. J. Barrios, and N. M. Greenberg Conditional Deletion of Rb Causes Early Stage Prostate Cancer Cancer Res., September 1, 2004; 64(17): 6018 - 6025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, H. Deng, I. Basu, and L. Zhu Induction of Androgen Receptor-Dependent Apoptosis in Prostate Cancer Cells by the Retinoblastoma Protein Cancer Res., February 15, 2004; 64(4): 1377 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lemjabbar, D. Li, M. Gallup, S. Sidhu, E. Drori, and C. Basbaum Tobacco Smoke-induced Lung Cell Proliferation Mediated by Tumor Necrosis Factor {alpha}-converting Enzyme and Amphiregulin J. Biol. Chem., July 3, 2003; 278(28): 26202 - 26207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bianco, D. J. Handelsman, J. S. Pedersen, and G. P. Risbridger Direct Response of the Murine Prostate Gland and Seminal Vesicles to Estradiol Endocrinology, December 1, 2002; 143(12): 4922 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Day, M. T. McCabe, X. Zhao, Y. Wang, J. N. Davis, J. Phillips, M. Von Geldern, T. Ried, M. A. KuKuruga, G. R. Cunha, et al. Rescue of Embryonic Epithelium Reveals That the Homozygous Deletion of the Retinoblastoma Gene Confers Growth Factor Independence and Immortality but Does Not Influence Epithelial Differentiation or Tissue Morphogenesis J. Biol. Chem., November 8, 2002; 277(46): 44475 - 44484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Park, J. E. Walls, J. J. Galvez, M. Kim, C. Abate-Shen, M. M. Shen, and R. D. Cardiff Prostatic Intraepithelial Neoplasia in Genetically Engineered Mice Am. J. Pathol., August 1, 2002; 161(2): 727 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shou, R. Soriano, S. W. Hayward, G. R. Cunha, P. M. Williams, and W.-Q. Gao Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression PNAS, March 5, 2002; 99(5): 2830 - 2835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, D. Sudilovsky, B. Zhang, P. C. Haughney, M. A. Rosen, D. S. Wu, T. J. Cunha, R. Dahiya, G. R. Cunha, and S. W. Hayward A Human Prostatic Epithelial Model of Hormonal Carcinogenesis Cancer Res., August 1, 2001; 61(16): 6064 - 6072. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
